These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15251744)

  • 1. Sequential occurrence of toxic nodular goiter followed by Graves' disease.
    Seplowitz AH; Ditkoff BA; Papadopoulos AD; Gerfo PL
    Endocr Pract; 1998; 4(3):150-2. PubMed ID: 15251744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
    Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
    Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
    Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
    Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Doppler Flow Parameters in the Ophthalmic Artery and Central Retinal Artery in Patients With Graves' Disease and Toxic Nodular Goiter.
    Walasik-Szemplińska D; Kamiński G; Mańczak M; Widłak J; Sudoł-Szopińska I
    Front Endocrinol (Lausanne); 2019; 10():707. PubMed ID: 31681176
    [No Abstract]   [Full Text] [Related]  

  • 7. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
    Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
    Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin B12 levels are not affected by radioiodine ablation of the thyroid.
    Potham SK; Vaikkakara S; Sachan A; Rao SP; Kalawat TC; Ravi P; Sunil E; Rajitha D; Arun M; Sailaja A
    Endocr Regul; 2014 Apr; 48(2):77-85. PubMed ID: 24824803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of smoking on Graves' disease with or without ophthalmopathy and nontoxic nodular goiter in Taiwan.
    Chen YL; Chang TC; Chen CJ
    J Formos Med Assoc; 1994 Jan; 93(1):40-4. PubMed ID: 7915579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
    Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graves' disease nd toxic nodular goiter--radioiodine therapy].
    Schicha H; Dietlein M
    Nuklearmedizin; 2002 Apr; 41(2):63-70. PubMed ID: 11989300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' disease induced by Na(131)I therapy for toxic multinodular goitre.
    van Leussen JJ; Edelbroek MA; Talsma MA; de Heide LJ
    Neth J Med; 2000 Nov; 57(5):194-7. PubMed ID: 11185482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
    Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial risks for hospitalized Graves' disease and goiter.
    Hemminki K; Shu X; Li X; Ji J; Sundquist K; Sundquist J
    Eur J Endocrinol; 2009 Oct; 161(4):623-9. PubMed ID: 19661127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperthyroidism and carcinoma of the thyroid gland].
    Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
    Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occurrence of immune hyperthyroidism after radioiodine therapy of autonomous goiter].
    Hirsch C; Spyra JL; Langhammer HR; Laubenbacher C; Senekowitsch-Schmidtke R; Schwaiger M
    Med Klin (Munich); 1997 Mar; 92(3):130-7. PubMed ID: 9173203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.